{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["26(5)"],"submitter":["Alkatiri AA"],"pubmed_abstract":["The indications for transfemoral transcatheter aortic valve replacement (TAVR) have been expanding; however, treatment protocol for patients with severe aortic stenosis with other significant valve disease is still controversial. Furthermore, there are few randomized data to guide therapy in multivalvular disease. We describe a successful percutaneous transvenous mitral commissurotomy and TAVR simultaneously. A 3-year follow-up echocardiography showed preserved valve function.<h4>Learning objective</h4>A combination of percutaneous transvenous mitral commissurotomy and transcatheter aortic valve replacement for multivalvular disease with severe mitral stenosis and aortic stenosis may be a treatment option. For multivalvular disease, heart team decisions can be valuable for an optimal manag"],"journal":["Journal of cardiology cases"],"pagination":["357-359"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9605916"],"repository":["biostudies-literature"],"pubmed_title":["Percutaneous transvenous mitral commissurotomy and transcatheter aortic valve replacement for rheumatic mitral and aortic stenosis."],"pmcid":["PMC9605916"],"pubmed_authors":["Saito S","Ochiai T","Shishido K","Moriyama N","Noguchi K","Firman D","Yamanaka F","Soerianata S","Alkatiri AA"],"additional_accession":[]},"is_claimable":false,"name":"Percutaneous transvenous mitral commissurotomy and transcatheter aortic valve replacement for rheumatic mitral and aortic stenosis.","description":"The indications for transfemoral transcatheter aortic valve replacement (TAVR) have been expanding; however, treatment protocol for patients with severe aortic stenosis with other significant valve disease is still controversial. Furthermore, there are few randomized data to guide therapy in multivalvular disease. We describe a successful percutaneous transvenous mitral commissurotomy and TAVR simultaneously. A 3-year follow-up echocardiography showed preserved valve function.<h4>Learning objective</h4>A combination of percutaneous transvenous mitral commissurotomy and transcatheter aortic valve replacement for multivalvular disease with severe mitral stenosis and aortic stenosis may be a treatment option. For multivalvular disease, heart team decisions can be valuable for an optimal manag","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-22T02:03:25.349Z","creation":"2025-04-05T20:14:40.364Z"},"accession":"S-EPMC9605916","cross_references":{"pubmed":["36312777"],"doi":["10.1016/j.jccase.2022.07.010"]}}